Gastrohepatic Disorders Resource Center

Click on the subcategory below to find drug monographs for that particular area.

Humira Gains Pediatric Chron's Indication

AbbVie announced that the Food and Drug Administration (FDA) has approved Humira (adalimumab) for reducing signs and symptoms, and achieving and maintaining clinical remission, in pediatric Crohn's disease for patients ≥6 years old when certain other treatments were inadequate.

Uceris Rectal Foam for Ulcerative Colitis

The FDA has granted tentative approval for Uceris (budesonide) rectal foam for the induction of remission in patients with active mild-to-moderate distal ulcerative colitis (UC).

First-in-Class Movantik Approved

The Food and Drug Administration has approved Movantik (naloxegol; AstraZeneca) for the treatment of opioid-induced constipation in adults with chronic non-cancer pain.

IBD and Opioid Use

There is limited data on the effectiveness of opioid analgesics in relieving symptoms such as abdominal pain and diarrhea associated with IBD.

Long-Term Data for Adalimumab

ased on placebo-controlled trials, the safety and efficacy of adalimumab therapy in UC patients has been reported up to Week 52.

Allergen in Gluten-Free Foods

The FDA has issued an alert regarding an ingredient commonly found in gluten-free products that may cause anaphylaxis in patients with a legume allergy.

New Drug Product: Entyvio

Moderately-to-severely active ulcerative colitis.

Chart: Bowel Cleansers

Review this chart for quick information when you need it.

Featured courses from mycme

Managing Fatty Liver, IBS, Colon Screening, and Hep C (Pharmacology Credit)External web site

This activity discusses GI conditions commonly encountered in primary care. This activity is accredited for ...

CE 1.00 Credits

Clinical review - Ulcerative colitisExternal web site

Clinical review - Ulcerative colitis

2.50 Credits

Pharmacology Update - GI (Pharmacology Credit)External web site

This activity will discuss the ways in which functional bowel disorders can impact patients and ...

CE 1.50 Credits

Sign Up for Free e-newsletters